Jeff Aronin: Leading Life Changing Developments at Paragon Biosciences
July 22, 2018
Jeff Aronin is an experienced medic who has done so much in this field. He is the founder of Paragon Biosciences. This is a body that seeks to provide treatment solutions, especially for rare ailments. The other primary aim of this firm is to improve the lives of human beings and, thus, ensuring that they live the longest time possible. Their technique of operation involves the development of drugs through their state of art biotechnology unit.
They also fund the development of other institutions that are committed to curbing diseases through the use of biotechnology technique. This institution is the brainchild of Jeff Aronin, and he always comes up with innovative measures to ensure that it remains relevant in fulfillment of its key objectives.
The firm was introduced with the aim of bringing to an end the numerous diseases that have no cure. Currently, in the world, innumerable ailments lead to death due to lack of treatment. Most of these ailments are bracketed in the rare ailments category. One of the reasons why these ailments have no cure is because they attack a small portion of the population. Most pharmaceutical drugs are out in business to make as much money as possible.
They, therefore, place greater emphasis on drug development of the primary diseases and ignore these rare ailments. Jeff Aronin believes that this is a wrong approach and every patient has a right to medical care. This sums up the philosophy of Paragon Biosciences and the firm have done everything that is possible to achieve this objective.
Paragon’s treatment strategy
This firm is well equipped regarding equipment and experienced staff who consider the patient’s well-being always in their work. The firm begins by identifying the rare ailments that attack patients. After detecting the disease, the firm’s research experts embark on a mission to study the illness and means of overcoming it. During this time, Paragon Biosciences’ experts investigative the causative agents of the disease as well as methods of containing it.
Afterward, the firm sponsors the production of drugs that will provide a long-term solution to the condition. This organization researches all parts of the world to ensure that they exhaust all possible drug development options. This ensures that they produce effective drugs.